| 摘要 |
The present invention relates to an asymmetric process for providing N-{2-[(1 S )-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]-1,3-dioxo-2,3-dihydro-1 H -isoindol-4-yl}acetamide (apremilast) or a pharmaceutically acceptable salt or solvate thereof. |
